According to The Insight Partners, “Hematology Analyzers & Reagents Market Size, Share, Growth, Trends and Global Forecast to 2027 – COVID-19 Impact and Global Analysis – by Product and Service (Hematology Products & Services, Hemostasis Products & Services, and Immunohematology Products & Services), Application (Anemia, Blood Cancer, Hemorrhagic Conditions, Infection Related Conditions, Immune System Related Conditions, and Other Applications), and End User (Hospital Laboratories, Commercial Service Providers, Government Reference Laboratories, and Research and Academic Institutes)”; The global hematology analyzers & reagents market size is projected to reach USD 13 billion by 2027 from USD 7.25 billion in 2019; it is estimated to grow at a CAGR of 7.6% during 2020–2027.
Download Sample Brochure at https://www.theinsightpartners.com/sample/TIPRE00003261
Global Hematology Analyzers & Reagents Market – Product Developments:
|2020||Beckman Coulter launched DxH 690T hematology analyzer in the U.S. Designed to streamline workflow and minimize downtime in mid-volume laboratories, the DxH 690T delivers all of the benefits of the company’s flagship DxH 900 large-volume hematology analyzer in a table-top configuration.|
|2019||ERBA Diagnostics Mannheim GmbH (Mannheim, Germany) launched its latest hematology analyzers at MedLab Middle East, an international platform for laboratory management and medicine that was held between February 4-7, 2019, at the Dubai International Convention and Exhibition Centre, Dubai, UAE|
|2019||HORIBA Medical and LABORATORIO ECHEVARNE, one of the major Laboratory Medicine providers in Europe have signed a multi-year, multi-site contract for the supply of the high range fully automated Hematology analyzers during the EuroMedLab congress|
The hematology analyzers and reagents market is highly competitive in nature with considerable number of players, having a high level of consolidation overall revenue share. Most of the companies operating in the hematology analyzers and reagents market are present globally and have wide distribution and sales network through partnerships or authorized dealers.
The most notable market participants are Clinical Diagnostic Solutions, Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Danaher, BIO-RAD LABORATORIES INC., Abbott, Diatron, ERBA Diagnostics Inc., EKF Diagnostics, HORIBA Medical, and Biosystems S.A. occupying a considerable share of the market owing to their offerings to the market.
Check Exclusive Discount on this Report at https://www.theinsightpartners.com/discount/TIPRE00003261
Impact of COVID-19 on Global Hematology Analyzers & Reagents Market Growth:
The COVID-19 pandemic is estimated to have a significant positive impact on the hematology analyzers and reagents market. Majority of the pharmaceutical companies across the world are engaged in the development of vaccines for COVID-19. Moreover, companies are now focusing on the development of the antibody-specific COVID-19 blood tests, which is anticipated to have a positive impact on the other segments of the market in the coming months. However, disruptions in the supply chain caused due to the halt in global operations are hindering the market growth.
The players operating in the hematology analyzers and reagents market are highly competitive and have been introducing novel products and reagents. For instance, in May 2020, Beckman Coulter introduced DxH 690T hematology analyzer in the US to streamline workflow and minimize the downtime in medium-sized laboratories. Moreover, in August 2020, IDEXX Laboratories, Inc. introduced ProCyte OneHematology Analyzer that helps deliver workflows with simplicity and consistency at the point of care. The company has also announced its plans for the global rollout of this product by early 2021. In addition, in July 2017, Sysmex launched the XN-L automated hematology analyzers in the US. Later in September 2018, it also launched XS-500ix in the Chinese market. The new product is an automated hematology analyzer of its XS-Series. Furthermore, in September 2020, Agappe Diagnostics, in collaboration with L&T Technology Services Limited, introduced its first indigenously developed hematology analyzer, Mispa Count X. The launches of such new products are fueling the growth of the hematology analyzers and reagents market.
Purchase Premium Copy of Hematology Analyzers & Reagents Market Growth Report (2020-2027) at: https://www.theinsightpartners.com/buy/TIPRE00003261
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
Press Release: https://www.theinsightpartners.com/pr/hematology-analyzers-and-reagents-market